Journal Article

Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy

D. Boucher, S. Hillier, D. Newsome, Y. Wang, D. Takemoto, Y. Gu, W. Markland, R. Hoover, R. Arimoto, J. Maxwell, S.Z. Fields, P. Charifson, M.S. Penney and K. Tanner

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 27, issue suppl_6 Published in print October 2016 | ISSN: 0923-7534
Published online October 2016 | e-ISSN: 1569-8041 | DOI: https://dx.doi.org/10.1093/annonc/mdw368.25
Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy

More Like This

Show all results sharing this subject:

  • Medical Oncology

GO

Show Summary Details

Journal Article.  368 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.